18 Oct 21. Edinburgh Imaging Radiochemistry - SALTIRE II
As the Edinburgh Imaging Radiochemistry facility temporarily closes for refurbishment, we look back at the facility's success with the SALTIRE II clinical trial.

The Edinburgh Imaging Radiochemistry facility was opened in 2010 & currently houses a cyclotron with supporting radiochemistry suites to create both GMP & research PET radiotracers.
The EI Radiochemistry facility has now temporarily closed for refurbishment.
SALTIRE II: bisphosphonates & RANKL inhibition in aortic stenosis, is a randomised controlled trial which uses imaging as a primary outcome endpoint, plus other imaging endpoints for secondary outcomes.
The Edinburgh Imaging Facility QMRI carries out the CT calcium scoring, which is the primary outcome endpoint.
The Edinburgh Imaging Radiochemistry facility produces 18F-NaF for PET-CT imaging of the vasculature for one of the secondary outcomes.
Relevant links
- Edinburgh Imaging
- Edinburgh Imaging facilities
- Edinburgh Imaging facility radiochemistry
- Edinburgh Imaging facility QMRI
- Edinburgh Imaging equipment
- Aortic stenosis
- SALTIRE II
- What is a PET-CT scan?
- What is a CT scan?
- 02 Aug 21. Radiochemistry 18F-FDG production milestone
- 27 Apr 21. Edinburgh Imaging FAPI accomplishment
Social media tags & titles
As the Edinburgh Imaging Radiochemistry facility temporarily closes for refurbishment, we look back at the facility's success with the SALTIRE II clinical trial.
@EdinUniMedicine @EdinburghBQ @MarcDweck @EdinUniCVS